Search

everythinglearnresearchcommunity

for

Search:↓

Primary idiopathic pseudopelade of Brocq causes gradual, scarring hair loss with no effective treatment.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Cyclosporin doesn't stop hair loss.

Terbinafine can cause hair loss.

The document concludes that understanding hair biology and recognizing hair conditions are crucial for managing and treating hair loss in children.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Trichofolliculoma, a rare benign hair follicle tumor, can potentially recur.

The document concludes that more research is needed to understand airway repair and to improve tissue engineering for lung treatments.

Nivolumab can cause hair loss as a rare side effect.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Dermatoscopy helps diagnose hair and scalp disorders in people with Afro-textured hair, but more research is needed for better understanding and treatment.

Wnt signaling is crucial for skin and hair development and its disruption can cause skin tumors.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

The article concludes that understanding the causes of hair loss and using continuous treatments like minoxidil and finasteride can help manage it, despite potential side effects.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Lipid nanoparticles improve drug delivery through the skin, offering stability, controlled release, and better compatibility with skin.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

Trichoscopy is a key method for dermatologists to quickly and effectively diagnose hair and scalp conditions.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

The document explains different hair loss types and treatments, emphasizing diagnosis through examination and tests, and specific treatments for each condition.

A new method using Platelet-rich Plasma (PRP) in a microneedle can promote hair regrowth more efficiently and is painless, minimally invasive, and affordable.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.